Celyad Oncology SA (NASDAQ:CYAD)

0.9997
BATS BZX Real-Time Price
As of Dec 02
 0.00 / 0.00%
Today’s Change
0.95
Today|||52-Week Range
5.10
-72.69%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Revenue and IncomeNet Revenues3.3K9.4M4.0M3.7M
 
 
 
 
 
Cost of Goods Sold1.1K58.5K586.9K0.00
 
 
 
 
Depreciation And Amortization1.1M1.7M2.0M1.3M
 
 
 
 
 
 
Operating ExpensesGross Income-1.1M7.7M1.5M2.4M
 
 
 
 
 
General Expenses32.0M39.6M34.8M40.4M
 
 
 
 
 
Other Operating Expenses-454.7K0.000.001.2M
 
 
 
Research And Development24.0M29.1M24.4M28.4M
 
 
 
 
 
Total Operating Expenses32.7M41.4M37.3M42.9M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-32.6M-32.0M-33.3M-39.2M
 
 
 
 
 
Extraordinary Charge0.000.00-29.9M-6.8M
 
 
 
Interest Expense On Debt48.6K120.3K164.1K72.0K
 
 
 
 
 
Equity In Earnings278.1K0.000.000.00
 
 
Other Expenses-101.5K4.5M-3.3M1.2M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-32.4M-26.1M-65.6M-44.5M
 
 
 
 
 
Income Taxes0.00-6.6K-1.3M-365.7K
 
 
 
 
Net Income-32.1M-26.1M-64.3M-44.2M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS8.5M9.3M9.6M11.1M
 
 
 
 
 
Shares To Calculate EPS Diluted8.5M9.3M9.6M11.1M
 
 
 
 
 
 
Earnings Per ShareEPS-$3.79-$2.79-$6.68-$3.96
 
 
 
 
 
EPS Diluted-$3.79-$2.79-$6.68-$3.96